A double-blind, randomized, controlled trial of 40 male patients with androgenetic alopecia was conducted. All subject were randomized to receive either combination of minoxidil 5% topical and finasteride 0,1% topical or minoxidil 5% topical
All subject were randomized to receive either combination of minoxidil 5% topical and finasteride 0,1% topical or minoxidil 5% topical The primary outcome was increase of the hair density and hair diameter (mean thickness) measured by trichoscan Measurements were done at baseline and every four weeks for twelve weeks. Additionally, side effects of therapy was also measured.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
40
finasteride topical 0,1%
minoxidil topical 5%
University Indonesia
Jakarta, Other (Non U.s.), Indonesia
RECRUITINGHair density
Density of the hair is the number of hair strands per square inch of the scalp measured by trichoscan
Time frame: 4 times of measurement in 3 months
Hair diameter (mean thickness)
Hair diameter is the midline of the hair shaft measured by trichoscan
Time frame: 4 times of measurement in 3 months
Side effects
Incidence of side effects
Time frame: 4 times of measurement in 3 months
Velus hair percentage ( hair rate vellus)
Vellus hair is a hair that is less than 30 micrometer in diameter, lacks a medulla hair, and is 2 cm in length measured by trichoscan
Time frame: 4 times of measurement in 3 months
Terminal hair percentage (hair rate terminal)
Terminal hair is a hair that has a hair more than 60 micrometer, contains the medulla and can be up to 100 cm in length measured by trichoscan
Time frame: 4 times of measurement in 3 months
Dermoscopy
Dermoscopy is a non-invasive technique that allows more detailed examination of the scalp and hair shaft under magnification
Time frame: 4 times of measurement in 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.